These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6448915)

  • 61. The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigra.
    Trugman JM; Wooten GF
    Brain Res; 1986 Aug; 379(2):264-74. PubMed ID: 3527339
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Metabolic mapping of the effects of intravenous methamphetamine administration in freely moving rats.
    Pontieri FE; Crane AM; Seiden LS; Kleven MS; Porrino LJ
    Psychopharmacology (Berl); 1990; 102(2):175-82. PubMed ID: 1980372
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Functional metabolic mapping of the rat brain during unilateral electrical stimulation of the subthalamic nucleus.
    Tzagournissakis M; Dermon CR; Savaki HE
    J Cereb Blood Flow Metab; 1994 Jan; 14(1):132-44. PubMed ID: 8263049
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Functional role for vasoactive intestinal polypeptide in the caudate nucleus: a 2-deoxy[14C]glucose investigation.
    McCulloch J; Kelly PA; Uddman R; Edvinsson L
    Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1472-6. PubMed ID: 6572400
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Suprachiasmatic nucleus: use of 14C-labeled deoxyglucose uptake as a functional marker.
    Schwartz WJ; Gainer H
    Science; 1977 Sep; 197(4308):1089-91. PubMed ID: 887940
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Deoxyglucose-autoradiography of the hypothalamus after food deprivation in the mouse.
    Lindroos F; Johansson G; Laakso ML
    Act Nerv Super (Praha); 1986 Jun; 28(2):81-6. PubMed ID: 3739572
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activation of brain regions in rats during food-intake operant behavior.
    Morimoto A; Suzumi M; Sakata Y; Murakami N
    Physiol Behav; 1984 Dec; 33(6):965-8. PubMed ID: 6537527
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake.
    Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
    Neurosci Lett; 1986 Jan; 63(1):61-5. PubMed ID: 3485267
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
    Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI
    Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease.
    Buck SH; Burks TF; Brown MR; Yamamura HI
    Brain Res; 1981 Mar; 209(2):464-9. PubMed ID: 6164436
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cerebral metabolic response to systemic kainic acid: 14-C-deoxyglucose studies.
    Collins RC; McLean M; Olney J
    Life Sci; 1980 Sep; 27(10):855-62. PubMed ID: 7412474
    [No Abstract]   [Full Text] [Related]  

  • 72. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
    Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
    Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Elevation of Met-enkephalin-like immunoreactivity in the rat striatum and globus pallidus following the focal injection of excitotoxins.
    Ruzicka BB; Jhamandas K
    Brain Res; 1990 Dec; 536(1-2):227-39. PubMed ID: 2150770
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizures.
    Clifford DB; Olney JW; Maniotis A; Collins RC; Zorumski CF
    Neuroscience; 1987 Dec; 23(3):953-68. PubMed ID: 3437996
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
    Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
    Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Kainic acid lesions of the striatum: behavioural sequalae similar to Huntington's chorea.
    Mason ST; Fibiger HC
    Brain Res; 1978 Oct; 155(2):313-29. PubMed ID: 28817
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Limbic brain structures are important sites of kappa-opioid receptor-mediated actions in the rat: a [14C]-2-deoxyglucose study.
    Ableitner A; Herz A
    Brain Res; 1989 Jan; 478(2):326-36. PubMed ID: 2538203
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of [14C]glucose and [14C]deoxyglucose as tracers of brain glucose use.
    Hawkins RA; Mans AM; Davis DW; DeJoseph MR
    Am J Physiol; 1988 Mar; 254(3 Pt 1):E310-7. PubMed ID: 3348390
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High resolution autoradiographic determination of the topographic distribution of radioactivity in the hippocampal formation after injection of [1-14C]glucose or 2-deoxy[14C]glucose.
    Duncan GE; Pilgrim C; Stumpf WE; McCown TJ; Breese GR; Mueller RA
    Neuroscience; 1986; 17(1):99-106. PubMed ID: 3960318
    [TBL] [Abstract][Full Text] [Related]  

  • 80. D1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervation.
    Trugman JM; James CL
    Brain Res; 1993 Apr; 607(1-2):270-4. PubMed ID: 8481802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.